CVS Health to hold third quarter 2025 earnings conference call
CVS Health (NYSE: CVS) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29th, 2025, at 8:00 a.m. ET. During this call, the company will discuss its Q3 2025 financial performance with analysts and investors.
The event will be accessible through an audio webcast on the Investor Relations section of CVS Health's website at investors.cvshealth.com. The webcast recording will remain available for replay on the website for one year following the event.
CVS Health (NYSE: CVS) ha programmato la conferenza sui risultati del terzo trimestre 2025 per mercoledì 29 ottobre 2025 alle 8:00 ET. Durante l'intervento, l'azienda discuterà la performance finanziaria del Q3 2025 con analisti e investitori.
L'evento sarà accessibile tramite audio webcast nella sezione Relazioni con gli Investitori del sito di CVS Health all'indirizzo investors.cvshealth.com. La registrazione del webcast resterà disponibile per la replica sul sito per un anno dopo l'evento.
CVS Health (NYSE: CVS) ha programado su conferencia de resultados del tercer trimestre de 2025 para miércoles, 29 de octubre de 2025 a las 8:00 a.m. ET. Durante la llamada, la compañía discutirá su desempeño financiero del Q3 2025 con analistas e inversores.
El evento estará disponible mediante audio webcast en la sección de Relaciones con Inversores del sitio web de CVS Health en investors.cvshealth.com. La grabación del webcast permanecerá disponible para su reproducción en el sitio durante un año tras el evento.
CVS Health (NYSE: CVS)는 2025년 3분기 실적 컨퍼런스 콜을 2025년 10월 29일 수요일 오전 8:00(동부 표준시)에 개최할 예정입니다. 이 전화에서 회사는 애널리스트 및 투자자와 함께 2025년 3분기 재무 실적에 대해 논의합니다.
행사는 CVS Health의 투자자 관계 섹션에 있는 오디오 생방송을 통해 이용 가능하며, 주소는 investors.cvshealth.com입니다. 생방송 녹화는 행사 후 1년 동안 웹사이트에서 재생 가능하도록 남아 있습니다.
CVS Health (NYSE: CVS) a prévu une conférence téléphonique sur les résultats du troisième trimestre 2025 pour le mercredi 29 octobre 2025 à 8h00, heure de l'Est. Au cours de cet appel, la société discutera de sa performance financière du T3 2025 avec les analystes et les investisseurs.
L'événement sera accessible via une diffusion audio en direct dans la section Relations investisseurs du site de CVS Health à l'adresse investors.cvshealth.com. L'enregistrement de la diffusion sera disponible en rediffusion sur le site pendant un an après l'événement.
CVS Health (NYSE: CVS) hat die Earnings-Konferenzschaltung für das dritte Quartal 2025 auf Mittwoch, den 29. Oktober 2025, um 8:00 Uhr ET angesetzt. Während dieses Anrufs wird das Unternehmen seine Finanzergebnisse des Q3 2025 mit Analysten und Investoren besprechen.
Die Veranstaltung ist über einen Audio-Webcast im Bereich Investor Relations der CVS Health-Website unter investors.cvshealth.com zugänglich. Die Webcast-Aufzeichnung wird für ein Jahr nach der Veranstaltung auf der Website zur Wiedergabe verfügbar bleiben.
حدّدت CVS Health (بورصة نيويورك: CVS) مكالمة مؤتمر الأرباح للربع الثالث من عام 2025 ليوم الأربعاء 29 أكتوبر 2025 في الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة. ستناقش الشركة خلال هذه المكالمة الأداء المالي للربع الثالث من عام 2025 مع المحللين والمستثمرين.
ستتاح الفعالية من خلال بث صوتي مباشر في قسم علاقات المستثمرين على موقع CVS Health الإلكتروني عند investors.cvshealth.com. وسيظل تسجيل البث الصوتي متاحاً لإعادة التشغيل على الموقع لمدة عام واحد بعد الحدث.
CVS Health (NYSE: CVS) 已将2025年第三季度财报电话会议安排在< b>2025年10月29日,星期三,美国东部时间上午8:00举行。在此次电话会议中,公司将与分析师和投资者讨论2025年第三季度的财务表现。
活动可通过CVS Health网站投资者关系板块的< b>音频网络直播进行访问,网址为< u>investors.cvshealth.com。网络直播的录音将在活动结束后一年的时间内在网站上提供回放。
- None.
- None.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
Ethan Slavin
860-273-6095
SlavinE@cvshealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@cvshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-hold-third-quarter-2025-earnings-conference-call-302570158.html
SOURCE CVS Health